PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a multicenter double-blind, placebo-controlled study to evaluate the safety, efficacy and pharmacokinetics of 2 doses of CXA-10 on stable background therapy in 96 subjects 18 to 80 years of age with PAH.
Epistemonikos ID: 4afd2ccb41b8575ce8283b3c0b173a6ff1433ce7
First added on: May 21, 2024